• HOME
  • Search & Results
  • Full Text
  • Thesis Details
 
Page: 202
 
Full Screen

  • TITLE
  • CERTIFICATE
  • DECLARATION
  • ACKNOWLEDGEMENT
  • CONTENTS
  • ABBREVIATIONS
  • I. Introduction and Objectives
  • Reference
  • 2. Solid Phase Peptide synthesis: An Overview of the Concepts an
  • 2.1 Principle
  • 2.2 The role of solid support
  • 2.3 Recent approaches in solid phase peptide synthesis
  • 2.3.a Peptide-resin linkage
  • 2.3.b Protecting schemes
  • 2.3.c C-terminal attachment
  • 2.3.d Activation reagents
  • 2.3.e Cleavage reagents
  • 2.4 Difficult couplings in solid phase peptide synthesis
  • 2.4.a Resin substitution
  • 2.4.b Elevated temperature
  • 2.4.c Insitu coupling additives
  • 2.4.d Solvation of the peptide chain
  • References
  • 3. Tri (propylene glycol) glycerolate-diacrylate Cross-linked Polystyrene:. Synthesis, Characterization and Functional Group Interconversions
  • 3.1 Introduction
  • 3.2 Results and discussion
  • 3.2.a. Synthesis and charecterisation of tri (propylene glycol) glycerolate diacrylate cross-linked polystyrene (PS-TRPGGDA) support
  • Fig. 3: Possible Lipophilic Presentations of the PS-TRPGGDA System
  • 3.2.b. Functional group interconversion
  • 3.2.c. Swelling studies of PS-TRPGGDA supports
  • 3.2.d. Chemical stability studies of PS-TRPGGDA support
  • 3.2.e. Derivatization of PS-TRPGGDA resin
  • 1. Synthesis of PS-TRPGGDA-HMPA resin
  • 2. Synthesis of PS-TRPGGDA-HMPB resin
  • 3. Synthesis of PS-TRPGGDA-Rink amide resin
  • 3.3. Experimental
  • 3.3.a. Materials
  • 3.3.b. Synthesis of PS-TRPGGDA polymer
  • 3.3.c. Swelling studies
  • 3.3.d. Chemical stability studies
  • 3.3.e. Functional group interconversion of the resin
  • 1. Chlorination
  • 2. Amination
  • 3.3. f. Derivatization of PS-TRPGGDA supports
  • 1. Preparation of PS-TRPGGDA-HMPA resin
  • 2. Preparation of PS-TRPGGDA-HMPB resin
  • 3. Preparation of PS-TRPGGDA-Rink amide resin
  • References
  • 4. Optimization of Peptide Synthetic Conditions on TRPGGDA Cross-linked Polystyrene Supports
  • 4.1 Introduction
  • 4.2 Results and discussion
  • 4.2.a C-Terminal amino acid incorporation to PS-TRPGGDA resin
  • 4.2.b Optimization of Na-deprotection studies
  • 1. Time dependent cleavage of Nα-Boc-Amino protection
  • 2. Time dependent cleavage of Na-Fmoc-Amino protection
  • 4.2.c Comparative study of solid phase amide bond formation using Leu-Aia-GIy-Val as model peptide
  • 4.2.d Peptide cleavage studies of PS-TRPGGDA support
  • 4.2.e Kinetic comparison of PS-TRPGGDA supports with Merrifield resin
  • 4.2.f Optimization of the PS-TRPGGDA support
  • 4.3 Experimental
  • 4.3.a Materials
  • 4.3.b Optimization of C-terminal amino acid incorporation studies
  • 1. Time dependent C-terminal Boc-amino acid incorporation
  • 2. Time-dependent C-terminal Fmoc-amino acid incorporation
  • 4.3.c Synthesis of PS-TRPGGDA-Val- (Ala) 4-Val-Boc and PS-DVB-Val (Ala) 4-V aI-Boc
  • 4.3.d Synthesis of PS-TRPGGDA-HMPA-Val- (Ala) 4-Val-Fmoc and PS-DVB-HMPA-Val (Ala) 4-Val-Fmoc
  • 4.3.e Optimization of Na-deprotection studies
  • 1. Time dependent Boc-deprotection
  • 2. Time dependent Fmoc-deprotection
  • 4.3.f Optimization of time and temperature dependent coupling
  • 4.3.g Time and temperature dependent cleavage of the peptide
  • 4.3.h Preparation of N-benzoylglycine 4-nitrophenyl ester
  • 4.3. i Aminolysis of N-benzoylglycine-4-nitrophenyl ester by C-terminal amino acid attached polymeric supports
  • References
  • 5. Comparative Study of PS-TRPGGDA Supports with Merrifield. Pam and Sheppard Resins
  • 5.1 Introduction
  • 5.2. Results and Discussion
  • 5.2.a. Synthesis of peptides using Boc-amino acids
  • 1. Comparative synthesis of retro acyl carrier (74-65) protein fragment
  • 5.2.b. Synthesis of peptides using Fmoc-chemistry
  • 1. Comparative synthesis of Leu-Ala-Gly-Val
  • 2. Comparative synthesis of acyl carrier protein (65-74) fragment
  • 3. Comparative synthesis of Ala-Arg- (Ala) 6-Lys peptide
  • 4. Comparative synthesis of 15 residue Syntide 2 peptide
  • 5. Comparative synthesis of 21 residue peptide amide of dermaseptin
  • 5.3. Experimental
  • 5.3.a. Materials
  • 5.3.b. Preparation of Boc-azide
  • 5.3.c Preparation of Boc-amino acids by Schnabels method
  • 5.3.d. Preparation of 1-hydroxybenzotriazole
  • 5.3.e. Methods for purification and characterisation of peptides
  • 1. Column chromatography
  • 2. Amino acid analysis
  • 3. Matrix assisted laser desorption ionisation mass spectroscopy
  • 5.3.f. Preparation of Boc-Val-PS-TRPGGDA resin
  • 5.3.g Comparative synthesis of retro acyl carrier protein (74-65) fragment
  • 5.3.h. Derivatisation of the resin with HMPA linker
  • I. Preparation of PS-TRPGGDA-HMPA resin
  • 2. Preparation of PS-DVB-HMPA resin
  • 5.3.i. Anchoring of C-terminal Fmoc-Val
  • 1. Preparation of Fmoc-Val- HMPA- PS-TRPGGDA resin
  • 2. Preparation of Fmoc-VaI-HMPA-PS-DVB resin
  • 5.3.j Comparative synthesis of Leu-Ala-Gly-Val
  • 5.3.k. Anchoring or C-terminal Fmoc-Gly
  • 1. Preparation of Fmoc-Gly-HMPA- PS-TRPGGDA resin
  • 2. Preparation of Fmoc-Gly- HMPA-PS-DVB resin
  • 5.3.l. Comparative synthesis of acyl carrier protein (65-74) fragment
  • 5.3.m. Anchoring of C-terminal Fmoc-Lys
  • I. Preparation of Fmoc-Lys-HMPA-PS-TRPGGDA resin
  • 2. Preparation of Fmoc-Lys-HMPA-PS-DVB resin
  • 5.3.n. Comparative synthesis of Ala-Arg- (Ala) 6-Lys peptide
  • 5.3.o Comparative synthesis of Syntide 2 Peptide
  • 5.3.p. Derivatisation of supports with rink amide linker
  • 1. Preparation of PS-TRPGGDA-Rink amide resin
  • 2. Preparation of Merrifield resin-Rink amide resin
  • 5.3.q. Anchoring of C-terminal Fmoc-Ala
  • 1. Preparation of Fmoc-Ala-Rink amide-PS-TRPGGDA resin.
  • 2. Preparation of Fmoc-Ala-Rink amide-Merrifield resin
  • 5.3.r. Comparative synthesis of 21 residue dermaseptin peptide amide
  • References
  • 6. Solid Phase Synthesis of Biologically Active Peptides Using PS-TRPGGDA Supports
  • 6.1. Introduction
  • 6.2. Results and Discussion
  • 6.2.a. Synthesis of peptides using Boc chemistry
  • 1. Leu-Gly-Ala-Leu-Gly-Ala
  • 2. Ala-Ala-Ala-Ala
  • 3. 17 residue Chicken IL-2 DNA peptide
  • 4. Ala-Cys-Ala-Pro-Pro-Ala-Asp-Arg-Ala-Thr-Arg-Ala
  • 6.2.b. Synthesis of peptides using Fmoc chemistry
  • 6.2.b.1. Synthesis of peptide substrates of Ca 2+/ calmodulin binding peptide
  • 6.2.b.1.a. Synthesis of NR2B peptide substrates of Ca2+/ calmodulin binding peptide
  • 6.2.b.1.b Synthesis of NR2A peptide substrates of Ca2+ / calmodulin binding peptide
  • 6.2.b. 1.c. Synthesis of NR2B mutated peptide substrate of Ca 2+/ calmodulin binding peptide using semiautomatic peptide synthesiser
  • 6.2.b.2. Synthesis of non-structural protein fragments of hepatitis C viral protein
  • 6.2.b.2.a. Synthesis of NS2 peptide fragment of hepatitis C viral protein
  • 6.2.b.2.b. Synthesis of NS3 peptide fragment of hepatitis C viral protein
  • 6.2.b.2.c. Synthesis of NS4 peptide fragment of hepatitis C viral protein
  • 6.2.b.2.d. Synthesis of NSF peptide fragment of hepatitis C viral protein
  • 6.2.b.3 Synthesis of HIV-1 Rev. NES peptide
  • 6.2.b.4. Synthesis of M10 mutant NES peptide
  • 6.2. b. 5. Synthesis of Tyr-Ser-Arg-Arg-Lys-Tyr-Ser-Ser-Trp-Tyr.
  • 6.2.b.6. Synthesis of Asn-Pro-Val-Tyr
  • 6.3. Experimental
  • 6.3.a Materials
  • 6.3.b. Synthesis of peptides using Boc chemistry
  • I. Leu-Giy-Ala-Leu-Gly-Ala
  • 2. Ala-Ala-Ala-Ala
  • 3. 17 residue Chicken IL-2 cDNA peptide
  • 4. Ala-Cys-Ata-Pro-Pro-Ala-Asp-Arg-Ala-Thr-Arg-Ala
  • 6.3.c. Synthesis of peptides using Fmoc chemistry
  • I. Synthesis of NR2B peptide substrates of Ca 2+ / calmodulin binding peptide
  • 2. Synthesis of NR2A peptide substrates of Ca2+ / calmodulin binding peptide
  • 3. Synthesis of NR 2B mutated peptide substrate of Ca2+ / calmodulin binding peptide using semiautomatic peptide synthesiser
  • 4. Synthesis of NS2 peptide fragment of hepatitis C viral protein
  • 5. Synthesis of NS3 peptide fragment of hepatitis C viral protein
  • 6. Synthesis of NS4 peptide fragment of hepatitis C viral protein
  • 7. Synthesis of NS5 peptide fragment of hepatitis C viral protein
  • 8. Synthesis of HIV-1 Rev. NES peptide
  • 9. Synthesis of M10 mutant NES peptide
  • 10. Synthesis of peptide Tyr-Ser-Arg-Arg-Lys-Tyr-Ser-Ser-Trp-Tyr
  • 11. Synthesis of Asn-Pro-Val-Tyr
  • References
  • 7. Summary